Delcath Systems, Inc. (DCTH) Stock

Delcath Systems, Inc. (DCTH) is a Healthcare stock trading at $11.71 (as of 2026-06-18), with a market capitalization of $372.14M and a trailing P/E of 1172.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Delcath Systems, Inc. is an interventional oncology company focused on treating primary and metastatic liver cancers in the United States and Europe. It develops and provides the HEPZATO kit, a melphalan for injection/hepatic delivery system, and supplies the CHEMOSAT hepatic delivery system device for use with melphalan at medical centers in Europe.

Valuation — source: SEC EDGAR (first-party)
Price$11.71
Market Cap$372.14M
P/E Ratio1172.0
EV / EBITDA-274.8
Price / Book3.59
Price / Sales4.47
DCF Value (model)$11.53
DCF Upside vs Price-1.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$85.23M
Net Margin3.2%
Return on Equity0.5%
Current Ratio11.24
Revenue Growth (YoY)129.1%
EPS Growth (YoY)-108.6%
FCF Growth (YoY)-209.0%
Financial Health — source: SEC EDGAR
Altman Z-Score15.43 (safe)
Valuation vs Sector & Industry
Stock P/E1172.0
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector5491.8%
vs Industry3592.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderRosalind Advisors, Inc. ($30.63M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOGerard J. Michel
Employees96
CountryUS
IPO Date2018-05-03

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Sight Sciences, Inc. (SGHT)
  • AngioDynamics, Inc. (ANGO)
  • ClearPoint Neuro, Inc. (CLPT)
  • Cerus Corporation (CERS)
  • CARLSMED, INC. (CARL)
  • Quanterix Corporation (QTRX)
  • SHOULDER INNOVATIONS, INC. (SI)
  • Profound Medical Corp. (PROF)
DCTH earnings history · DCTH institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.